Lv Fengxia, Li Pan, Wang Bin, Zhao Menglu, Ji Peng, Dong Shishan
College of Veterinary Medicine, Hebei Agricultural University, Baoding, China.
Henan Muxiang Biological Co., Ltd., Zhengzhou, China.
Front Vet Sci. 2025 Jun 18;12:1628570. doi: 10.3389/fvets.2025.1628570. eCollection 2025.
INTRODUCTION: Zengye granule (ZYG), a traditional Chinese medicine, is listed in the Chinese Pharmacopoeia as a prescription medicine for treating various yin-deficiency diseases including inner heat, dry mouth and pharynx, and dry bound stool. However, the underlying mechanisms of its action remain unclear. This study aimed to assess the laxative effects of ZYG on diphenoxylate-induced constipation in Kunming mice and clarify the underlying mechanism of action of ZYG in treating constipation. METHODS: A model of constipation induced by diphenoxylate was developed. The laxative effect was evaluated based on the discharge time of the first black stool, fecal number, fecal weight, intestinal propulsion rate, and intestinal moisture content. Enzyme-linked immunosorbent assay was used to analyze the expression of inflammatory cytokines and neurotransmitters in serum. Histopathological analysis of colon tissues was performed using hematoxylin-eosin staining. Real-time quantitative polymerase chain reaction, immunohistochemistry, and western blotting were used to analyze the mRNA and protein expression of the stem cell factor (SCF)/c-Kit tyrosine kinase (c-Kit) signaling pathway. The composition of the mouse intestinal microbiota was determined by 16S rDNA sequencing. RESULTS: ZYG improved intestinal peristalsis, defecation frequency, and intestinal moisture content. ZYG decreased the abundance of at the phylum and genus levels and increased the abundance of at the genus level. ZYG exerted a laxative effect by modulating the SCF/c-Kit signaling pathway. DISCUSSION: This study provides valuable insights into laxative mechanism of ZYG and its potential veterinary application.
引言:中药增液颗粒(ZYG)被《中国药典》列为治疗多种阴虚病症的处方药,这些病症包括内热、口干咽燥和大便干结。然而,其作用的潜在机制仍不清楚。本研究旨在评估增液颗粒对苯乙哌啶诱导的昆明小鼠便秘的缓泻作用,并阐明增液颗粒治疗便秘的潜在作用机制。 方法:建立苯乙哌啶诱导的便秘模型。基于首次排出黑色粪便的时间、粪便数量、粪便重量、肠道推进率和肠道水分含量评估缓泻效果。采用酶联免疫吸附测定法分析血清中炎性细胞因子和神经递质的表达。使用苏木精-伊红染色对结肠组织进行组织病理学分析。采用实时定量聚合酶链反应、免疫组织化学和蛋白质印迹法分析干细胞因子(SCF)/c-Kit酪氨酸激酶(c-Kit)信号通路的mRNA和蛋白质表达。通过16S rDNA测序确定小鼠肠道微生物群的组成。 结果:增液颗粒改善了肠道蠕动、排便频率和肠道水分含量。增液颗粒在门和属水平降低了[具体菌属名称未给出]的丰度,在属水平增加了[具体菌属名称未给出]的丰度。增液颗粒通过调节SCF/c-Kit信号通路发挥缓泻作用。 讨论:本研究为增液颗粒的缓泻机制及其潜在的兽医应用提供了有价值的见解。
Cochrane Database Syst Rev. 2022-3-29
Cochrane Database Syst Rev. 2017-1-24
Front Biosci (Landmark Ed). 2025-6-17
Am J Transl Res. 2024-10-15
NPJ Biofilms Microbiomes. 2023-9-23
J Ethnopharmacol. 2024-1-10
Microorganisms. 2023-2-24